Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

FOCIS 2015: Metabolism May Affect Immune System’s Reaction to Disease

Catherine Kolonko  |  Issue: October 2015  |  October 13, 2015

Carol and Mike Werner/sciencesource.com

Image Credit: Carol and Mike Werner/sciencesource.com

How the immune system reacts to potential harm, such as lack of oxygen and inflammation, depends greatly on the human body’s metabolic processes and pathways, according to speakers at FOCIS 2015 in San Diego this past June.

During a session devoted to metabolism and the immune system, researchers talked about recent studies that shed light on the body’s response to disease that could lead to a better understanding on prevention and treatment. The discussion began on a high-profile topic of chronic inflammation and a recent discovery of a key protein.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Calorie Restriction

The anti-inflammatory effects of consuming fewer calories appear to be linked to a compound molecule that can inhibit the inflammasome complex that drives some chronic diseases, said Vishwa Deep Dixit, PhD, a professor at Yale University School of Medicine, New Haven, Conn., during a discussion on how calorie restriction influences the immune system.

“When you calorie restrict animals, ranging from a worm all the way up to primates, it’s known that [doing so] substantially reduces the disease burden,” Dr. Dixit said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Dixit

Dr. Dixit

A compound called β-hydroxybutyrate (BHB) has been found to block the NLRP3 inflammasome, he said. As part of a complex group of proteins, NLRP3 is responsible for triggering inflammation in immune cells.

Inflammation drives several chronic diseases, such as Alzheimer’s, atherosclerosis and gout. Dr. Dixit outlined studies conducted by Yale School of Medicine researchers that revealed that BHB suppresses activation of the NLRP3 inflammasome in response to the presence of urate crystals, adenosine triphosphate and lipotoxic fatty acids. Such conditions as calorie restriction, fasting and high-intensity exercise prompt the body to produce higher ketone metabolite levels of BHB. Starvation or consumption of a low-carbohydrate ketogenic diet also produces the metabolite, Dr. Dixit said.

Under starvation conditions, the body burns fat, which increases ketones that replace glucose as a source of energy to the brain and other parts of the body. However, Dr. Dixit said it is unknown how these and other metabolic fuels produced during energy deficits exactly influence the innate immune response.

It has been recognized that a starkly reduced intake of calories or fasting tends to diminish inflammation. With this in mind, researchers studying mice and human immune cells looked at how macrophages react to ketone bodies induced by restriction of calories, Dr. Dixit said.

Results from the study showed that BHB blocked the NLRP3 inflammasome by blocking a central adaptor protein needed for inflammation to occur. The significance of the discovery of this compound is that it could be useful in treatments of many inflammatory-driven conditions and diseases, Dr. Dixit said in his closing remarks.

Role of T Cells

The immune system comes into play again when talking about metabolic pathways in cancer and the important job of memory T cells to fight off pathogens., professor of biological sciences at the University of California, San Diego, spoke of her lab’s research on T cell differentiation and immunological memory. Her discussion focused mostly on regulators of the killer T cell immune response.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsMeeting Reports Tagged with:ClinicalDiseaseImmune Systemmetabolismoutcomepatient care

Related Articles

    The Expanded Role of the Inflammasome in Human Disease

    August 1, 2010

    Exploring advances, evaluating what remains to be done

    Cryopyrin-Associated Periodic Syndromes: Difficult to Recognize, Diagnose, Treat

    October 1, 2014

    Two case studies demonstrate the difficulty, delay in recognizing this rare autoinflammatory disease

    AJPhoto / Science Source

    Tips for Diagnosing Metabolic Myopathies

    September 17, 2019

    When evaluating patients with possible myopathic symptoms, rheumatologists must consider a rare, but important, group of inherited disorders: the metabolic myopathies. However, their diagnosis often remains a challenge. Early recognition of these primary metabolic myopathies is essential to help prevent disease morbidity and mortality from rhabdomyolysis. Here, we focus on the metabolic myopathies that present…

    2015 ACR/ARHP Annual Meeting: Metabolic Pathways Linked with Inflammatory Diseases

    February 16, 2016

    SAN FRANCISCO—Metabolomics could one day be a treasure map of information about inflammation in rheumatic disease. There are many metabolic pathways to pursue for clues on how to reverse this damaging process. “All of these signaling pathways are interrelated and affect each other,” said Douglas J. Veale, MD, director of translational research at Dublin Academic…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences